Filed: 2/10/2023ACC: 0001104659-23-018131
📋 What this filing means
TEKLA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 172 equity positions with a total reported market value of $2.65B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
172
Positions
$2.65B
Total AUM (reported)
38.07M
Total Shares
Allocation by class
COMMON$2.34B88.2%
SPONSORED ADR$167.42M6.3%
SHARES$84.26M3.2%
SPONSORED ADS$20.84M0.8%
CLASS A$20.06M0.8%
S&P BIOTECH ETF$12.26M0.5%
NAMEN AKT$2.24M0.1%
Portfolio Concentration
Top 3$406.71M15.4%
4–10$629.35M23.8%
11–25$719.78M27.2%
Rest$892.00M33.7%
Top 3 weight
15.4%
Top 10 weight
39.1%
Voting Authority Distribution
Total shares with voting rights: 2.65B
Sole
Full voting authority
2.65B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole172
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings172
Rows:
Unitedhealth Group Inc.
SOLEShares270.55K
TypeSH
Market value$143.44M
5.42%
Sole
143.44M
Shared
0.00
None
0.00
Amgen Inc.
SOLEShares508.68K
TypeSH
Market value$133.60M
5.05%
Sole
133.60M
Shared
0.00
None
0.00
Gilead Sciences, Inc.
SOLEShares1.51M
TypeSH
Market value$129.67M
4.90%
Sole
129.67M
Shared
0.00
None
0.00
Johnson & Johnson
SOLEShares639.68K
TypeSH
Market value$113.00M
4.27%
Sole
113M
Shared
0.00
None
0.00
Eli Lilly and Company
SOLEShares288.92K
TypeSH
Market value$105.70M
3.99%
Sole
105.70M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc.
SOLEShares330.34K
TypeSH
Market value$95.40M
3.60%
Sole
95.40M
Shared
0.00
None
0.00
Regeneron Pharmaceuticals, Inc.
SOLEShares120.86K
TypeSH
Market value$87.20M
3.29%
Sole
87.20M
Shared
0.00
None
0.00
AbbVie Inc.
SOLEShares478.34K
TypeSH
Market value$77.30M
2.92%
Sole
77.30M
Shared
0.00
None
0.00
Abbott Laboratories
SOLEShares693.05K
TypeSH
Market value$76.09M
2.87%
Sole
76.09M
Shared
0.00
None
0.00
Pfizer Inc.
SOLEShares1.46M
TypeSH
Market value$74.67M
2.82%
Sole
74.67M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares1.02M
TypeSH
Market value$69.31M
2.62%
Sole
69.31M
Shared
0.00
None
0.00
Illumina, Inc.
SOLEShares319.96K
TypeSH
Market value$64.70M
2.44%
Sole
64.70M
Shared
0.00
None
0.00
Merck & Co., Inc.
SOLEShares552.12K
TypeSH
Market value$61.26M
2.31%
Sole
61.26M
Shared
0.00
None
0.00
Cigna Corp.
SOLEShares182.63K
TypeSH
Market value$60.51M
2.29%
Sole
60.51M
Shared
0.00
None
0.00
Biogen Inc.
SOLEShares195.43K
TypeSH
Market value$54.12M
2.04%
Sole
54.12M
Shared
0.00
None
0.00
Thermo Fisher Scientific Inc.
SOLEShares93.70K
TypeSH
Market value$51.60M
1.95%
Sole
51.60M
Shared
0.00
None
0.00
Bristol-Myers Squibb Company
SOLEShares687.53K
TypeSH
Market value$49.47M
1.87%
Sole
49.47M
Shared
0.00
None
0.00
Moderna, Inc.
SOLEShares264.93K
TypeSH
Market value$47.59M
1.80%
Sole
47.59M
Shared
0.00
None
0.00
Horizon Therapeutics plc
SOLEShares415.05K
TypeSH
Market value$47.23M
1.78%
Sole
47.23M
Shared
0.00
None
0.00
Stryker Corp.
SOLEShares164.13K
TypeSH
Market value$40.13M
1.52%
Sole
40.13M
Shared
0.00
None
0.00
Humana Inc.
SOLEShares77.71K
TypeSH
Market value$39.80M
1.50%
Sole
39.80M
Shared
0.00
None
0.00
Boston Scientific Corp.
SOLEShares757.01K
TypeSH
Market value$35.03M
1.32%
Sole
35.03M
Shared
0.00
None
0.00
Alnylam Pharmaceuticals, Inc.
SOLEShares143.21K
TypeSH
Market value$34.03M
1.29%
Sole
34.03M
Shared
0.00
None
0.00
Zimmer Biomet Holdings, Inc.
SOLEShares258.87K
TypeSH
Market value$33.01M
1.25%
Sole
33.01M
Shared
0.00
None
0.00
United Therapeutics Corp.
SOLEShares115.08K
TypeSH
Market value$32.00M
1.21%
Sole
32M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Unitedhealth Group Inc.SOLE | Common | 270.55K | SH | $143.44M 5.42% | 143.44M | 0.00 | 0.00 |
Amgen Inc.SOLE | Common | 508.68K | SH | $133.60M 5.05% | 133.60M | 0.00 | 0.00 |
Gilead Sciences, Inc.SOLE | Common | 1.51M | SH | $129.67M 4.90% | 129.67M | 0.00 | 0.00 |
Johnson & JohnsonSOLE | Common | 639.68K | SH | $113.00M 4.27% | 113M | 0.00 | 0.00 |
Eli Lilly and CompanySOLE | Common | 288.92K | SH | $105.70M 3.99% | 105.70M | 0.00 | 0.00 |
Vertex Pharmaceuticals Inc.SOLE | Common | 330.34K | SH | $95.40M 3.60% | 95.40M | 0.00 | 0.00 |
Regeneron Pharmaceuticals, Inc.SOLE | Common | 120.86K | SH | $87.20M 3.29% | 87.20M | 0.00 | 0.00 |
AbbVie Inc.SOLE | Common | 478.34K | SH | $77.30M 2.92% | 77.30M | 0.00 | 0.00 |
Abbott LaboratoriesSOLE | Common | 693.05K | SH | $76.09M 2.87% | 76.09M | 0.00 | 0.00 |
Pfizer Inc.SOLE | Common | 1.46M | SH | $74.67M 2.82% | 74.67M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | Sponsored ADR | 1.02M | SH | $69.31M 2.62% | 69.31M | 0.00 | 0.00 |
Illumina, Inc.SOLE | Common | 319.96K | SH | $64.70M 2.44% | 64.70M | 0.00 | 0.00 |
Merck & Co., Inc.SOLE | Common | 552.12K | SH | $61.26M 2.31% | 61.26M | 0.00 | 0.00 |
Cigna Corp.SOLE | Common | 182.63K | SH | $60.51M 2.29% | 60.51M | 0.00 | 0.00 |
Biogen Inc.SOLE | Common | 195.43K | SH | $54.12M 2.04% | 54.12M | 0.00 | 0.00 |
Thermo Fisher Scientific Inc.SOLE | Common | 93.70K | SH | $51.60M 1.95% | 51.60M | 0.00 | 0.00 |
Bristol-Myers Squibb CompanySOLE | Common | 687.53K | SH | $49.47M 1.87% | 49.47M | 0.00 | 0.00 |
Moderna, Inc.SOLE | Common | 264.93K | SH | $47.59M 1.80% | 47.59M | 0.00 | 0.00 |
Horizon Therapeutics plcSOLE | Common | 415.05K | SH | $47.23M 1.78% | 47.23M | 0.00 | 0.00 |
Stryker Corp.SOLE | Common | 164.13K | SH | $40.13M 1.52% | 40.13M | 0.00 | 0.00 |
Humana Inc.SOLE | Common | 77.71K | SH | $39.80M 1.50% | 39.80M | 0.00 | 0.00 |
Boston Scientific Corp.SOLE | Common | 757.01K | SH | $35.03M 1.32% | 35.03M | 0.00 | 0.00 |
Alnylam Pharmaceuticals, Inc.SOLE | Common | 143.21K | SH | $34.03M 1.29% | 34.03M | 0.00 | 0.00 |
Zimmer Biomet Holdings, Inc.SOLE | Common | 258.87K | SH | $33.01M 1.25% | 33.01M | 0.00 | 0.00 |
United Therapeutics Corp.SOLE | Common | 115.08K | SH | $32.00M 1.21% | 32M | 0.00 | 0.00 |
Page 1 of 7
…